P682: ACMG ACT Sheets and Algorithms: Update process, development, and utilization

Bibliographic Details
Published in:	Genetics in Medicine Open
Main Authors:	Molly Caisse, Megan Lyon, Nancy Rose
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423007549

Similar Items

P681: Disseminating genetics policy information on social media
by: Molly Caisse, et al.
Published: (2023-01-01)

P878: Federal legislation related to the genetics service delivery system: 2023 trends
by: Molly Caisse, et al.
Published: (2024-01-01)

O55: Proposed genetics legislation and regulation in the United States
by: Megan Lyon, et al.
Published: (2023-01-01)

P757: Clinical utility of the 2021 ACMG gene tiers in expanded carrier screening*
by: Dana Neitzel, et al.
Published: (2024-01-01)

P691: Comparing genetics policies in state Medicaid programs in 2022 vs 2021
by: Megan Lyon, et al.
Published: (2023-01-01)

Tyr(682) in the intracellular domain of APP regulates amyloidogenic APP processing in vivo.
by: Alessia P M Barbagallo, et al.
Published: (2010-11-01)

P681: Carrier screening with the ACMG 113: An early look and new insights
by: Vivienne Souter, et al.
Published: (2024-01-01)

P541: Updating patient results for genomic CNVs intersecting dosage sensitive genes on the ACMG secondary findings v3.1 list
by: Zoe Lewis, et al.
Published: (2023-01-01)

Updated ACMG/AMP specifications for variant interpretation and gene curations from the ClinGen RASopathy expert panels
by: Emma H. Wilcox, et al.
Published: (2025-01-01)

P452: Specifying the ACMG/AMP variant sequence interpretation guidelines for congenital myopathies*
by: Marina DiStefano, et al.
Published: (2023-01-01)

P652: Considerations of variant interpretation in galactosemia: Challenges of creating ACMG specifications for GALT
by: Alexa Dickson, et al.
Published: (2025-01-01)

Utility of ACMG classification to support interpretation of molecular genetic test results in patients with factor VII deficiency
by: Rosa Sonja Alesci, et al.
Published: (2023-07-01)

Expanding ACMG variant classification guidelines into a general framework
by: Emmanuelle Masson, et al.
Published: (2022-08-01)

P625: Utility of highest pathogenic variant frequency approach for application of BA1/BS1 ACMG criteria to reduce variants of uncertain significance
by: Kyle Salsbery, et al.
Published: (2024-01-01)

P430: Application of ACMG/AMP variant classification guidelines to Alzheimer’s disease-associated genetic variation
by: Alexa Dickson, et al.
Published: (2023-01-01)

P672: Commercial cystic fibrosis carrier screening tests and coverage of the ACMG 100 recommended variants
by: Timothy Tidwell, et al.
Published: (2024-01-01)

P682: Development of TAF1 genotyping assay for X-linked dystonia-parkinsonism-associated haplotype detection
by: Eirini Christodoulou, et al.
Published: (2025-01-01)

P682: Phenotype expansion or multilocus variants? Additional molecular findings in patients with well-known chromosomal disorders
by: Amir Hossein Saeidian, et al.
Published: (2024-01-01)

P835: Practical implementation of ACOG and ACMG carrier screening guidelines at a single academic medical center
by: Emily O'Brien, et al.
Published: (2025-01-01)

P393: Elevated prevalence of ACMG medically actionable variants in women with Mayer-Rokitansky-Küster-Hauser syndrome
by: John Theisen, et al.
Published: (2024-01-01)

P046: ACMG/AMP variant classification framework in arginase 1 deficiency: Implications for birth prevalence estimates and diagnostics
by: Mayowa Osundiji, et al.
Published: (2024-01-01)

WCN24-682 VALIDATION OF ALBUMIN CREATININE RATIO POINT OF CARE DEVICES FOR COMMUNITY TESTING
by: Kathryn Griffiths, et al.
Published: (2024-04-01)

P645: Creation of a ClinGen standard operating procedure to guide gene- and disease-specific refinements of the ACMG/AMP criteria
by: Alicia Byrne, et al.
Published: (2023-01-01)

Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework
by: Liting Cheng, et al.
Published: (2020-01-01)

Reclassification of Whole Exome Sequencing-derived Genetic Variants in Pendred Syndrome with ACMG/AMP Standards
by: Kok-Siong Poon, et al.
Published: (2021-03-01)

Improving genetic diagnosis by disease-specific, ACMG/AMP variant interpretation guidelines for hearing loss
by: So Young Kim, et al.
Published: (2022-07-01)

The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682YENPTY687 motif
by: Carmela Matrone
Published: (2023-01-01)

The thirty rules of Arabic science for Shihab al-Din al-Qurafi, who died in 682 AH
by: Taha Mohseen
Published: (1980-12-01)

P106: Population based reporting of ACMG78 secondary findings using semi-automated variant interpretation software for variant prioritization and curation*
by: Jennifer Arroyo, et al.
Published: (2023-01-01)

P493: Disease burden of DCM genes newly added to ACMG secondary findings via population genomic screening: Impact of TTN and FLNC
by: Melissa Kelly, et al.
Published: (2023-01-01)

P753: Variant interpretation of high-penetrance breast cancer genes in underrepresented populations: A review of ACMG guideline adherence and hypothetical data
by: Kelly Landucci, et al.
Published: (2025-01-01)

P682: THE RESULTS OF THE RUSSIAN PROSPECTIVE STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI (READIT-2020) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE
by: Margarita Gurianova, et al.
Published: (2023-08-01)

ACMG/AMP variant classification framework in arginase 1 deficiency: Implications for birth prevalence estimates and diagnostics
by: Jessie M. Cameron, et al.
Published: (2024-01-01)

Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer’s Disease Patients
by: Filomena Iannuzzi, et al.
Published: (2020-07-01)

The relationship between land surface temperature and artificial impervious surface fraction in 682 global cities: spatiotemporal variations and drivers
by: Qiquan Yang, et al.
Published: (2021-01-01)

Generation of an Alagille syndrome (ALGS) patient-derived induced pluripotent stem cell line (TRNDi032-A) carrying a heterozygous mutation (p.Cys682Leufs*7) in the JAG1 gene
by: Omer Hatim, et al.
Published: (2023-12-01)

Identification and characterization of the powdery mildew resistance in cultivated emmer wheat accession Lxd-682 via bulked segregant RNA sequencing
by: Jiatong Li, et al.
Published: (2025-05-01)

Genetic investigation of XPA gene: high frequency of the c.682C>T mutation in Moroccan XP patients with moderate clinical profile
by: Zineb Kindil, et al.
Published: (2017-12-01)

P250: Clarification of variant reporting for homologous genes resolved through systematic literature review: ACMG SF genes CALM1, CALM2, and CALM3
by: Kathryn Curry, et al.
Published: (2024-01-01)

O11: Defining the pleiotropic GATA2 deficiency phenotype for the development of ACMG-AMP variant curation rules for GATA2*
by: Shruthi Mohan, et al.
Published: (2023-01-01)